Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains

被引:28
作者
Araripe Sucupira, Maria Cecilia [1 ]
Sanabani, Sabri [2 ]
Cortes, Rodrigo M. [1 ]
Giret, Maria Teresa M. [3 ]
Tomiyama, Helena [1 ]
Sauer, Mariana M. [1 ]
Sabino, Ester Cerdeira [4 ]
Janini, Luiz Mario [5 ]
Kallas, Esper Georges [3 ]
Diaz, Ricardo Sobhie [1 ]
机构
[1] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil
[2] Fundacao Pro Sangue, Sao Paulo Blood Bank, Sao Paulo, Brazil
[3] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[4] Univ Sao Paulo, Div Infect Dis, Sao Paulo, Brazil
[5] Univ Fed Sao Paulo, Div Microbiol, Sao Paulo, Brazil
来源
PLOS ONE | 2012年 / 7卷 / 01期
关键词
VIRUS TYPE-1 SUBTYPES; T-CELL-ACTIVATION; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; GENETIC RESTRICTION; ENZYME-IMMUNOASSAY; CORECEPTOR USAGE; PROGNOSTIC VALUE; AIDS; VARIANTS;
D O I
10.1371/journal.pone.0030292
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Primary HIV infection is usually caused by R5 viruses, and there is an association between the emergence of CCXR4-utilizing strains and faster disease progression. We characterized HIV-1 from a cohort of recently infected individuals in Brazil, predicted the virus's co-receptor use based on the env genotype and attempted to correlate virus profiles with disease progression. Methods: A total of 72 recently infected HIV patients were recruited based on the Serologic Testing Algorithm for Recent HIV Seroconversion and were followed every three to four months for up to 78 weeks. The HIV-1 V3 region was characterized by sequencing nine to twelve weeks after enrollment. Disease progression was characterized by CD4+ T-cell count decline to levels consistently below 350 cells/mu L. Results: Twelve out of 72 individuals (17%) were predicted to harbor CXCR4-utilizing strains; a baseline CD4,350 was more frequent among these individuals (p = 0.03). Fifty-seven individuals that were predicted to have CCR5-utilizing viruses and 10 individuals having CXCR4-utilizing strains presented with baseline CD4.350; after 78 weeks, 33 individuals with CCR5 strains and one individual with CXCR4 strains had CD4.350 (p = 0.001). There was no association between CD4 decline and demographic characteristics or HIV-1 subtype. Conclusions: Our findings confirm the presence of strains with higher in vitro pathogenicity during early HIV infection, suggesting that even among recently infected individuals, rapid progression may be a consequence of the early emergence of CXCR4-utilizing strains. Characterizing the HIV-1 V3 region by sequencing may be useful in predicting disease progression and guiding treatment initiation decisions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Accetturi CA, 2000, J ACQ IMMUN DEF SYND, V24, P399, DOI 10.1097/00126334-200008010-00016
  • [2] High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos, Brazil
    Araripe Sucupira, Maria Cecilia
    Caseiro, Marcos Montani
    Alves, Katia
    Tescarollo, Graziela
    Janini, Luiz Mario
    Sabino, Ester Cerdeira
    Castelo, Adauto
    Page-Shafer, Kim
    Diaz, Ricardo Sobhie
    [J]. AIDS PATIENT CARE AND STDS, 2007, 21 (02) : 116 - 128
  • [3] Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
    Bennett, Diane E.
    Camacho, Ricardo J.
    Otelea, Dan
    Kuritzkes, Daniel R.
    Fleury, Herve
    Kiuchi, Mark
    Heneine, Walid
    Kantor, Rami
    Jordan, Michael R.
    Schapiro, Jonathan M.
    Vandamme, Anne-Mieke
    Sandstrom, Paul
    Boucher, Charles A. B.
    van de Vijver, David
    Rhee, Soo-Yon
    Liu, Tommy F.
    Pillay, Deenan
    Shafer, Robert W.
    [J]. PLOS ONE, 2009, 4 (03):
  • [4] Transmission networks of drug resistance acquired in primary/early stage HIV infection
    Brenner, Bluma G.
    Roger, Micho
    Moisi, Danma D.
    Oliveira, Maureen
    Hardy, Isabelle
    Turgel, Reuven
    Charest, Hugues
    Routy, Jean-Pierre
    Wainberg, Mark A.
    [J]. AIDS, 2008, 22 (18) : 2509 - 2515
  • [5] Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation
    Busch, Michael P.
    Pilcher, Christopher D.
    Mastro, Timothy D.
    Kaldor, John
    Vercauteren, Gaby
    Rodriguez, William
    Rousseau, Christine
    Rehle, Thomas M.
    Welte, Alex
    Averill, Megan D.
    Calleja, Jesus M. Garcia
    [J]. AIDS, 2010, 24 (18) : 2763 - 2771
  • [6] Casseb J, 2002, INT J INFECT DIS, V6, P164
  • [7] Monocyte-mediated T cell suppression by HIV-2 envelope proteins
    Cavaleiro, Rita
    Brunn, Gregory J.
    Albuquerque, Adriana S.
    Victorino, Rui M. M.
    Platt, Jeffrey L.
    Sousa, Ana E.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (12) : 3435 - 3444
  • [8] Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India
    Cecilia, D
    Kulkarni, SS
    Tripathy, SP
    Gangakhedkar, RR
    Paranjape, RS
    Gadkari, DA
    [J]. VIROLOGY, 2000, 271 (02) : 253 - 258
  • [9] Less sensitive HIV-1 enzyme immunoassay as an adjuvant method for monitoring patients receiving antiretroviral therapy
    Cimerman, Sergio
    Araripe Sucupira, Maria Cecilia
    Lewi, David Salomao
    Diaz, Ricardo Sobhie
    [J]. AIDS PATIENT CARE AND STDS, 2007, 21 (02) : 100 - 105
  • [10] Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters
    de Mendoza, Carmen
    Van Baelen, Kurt
    Poveda, Eva
    Rondelez, Evelien
    Zahonero, Natalia
    Stuyver, Lieven
    Garrido, Carolina
    Villacian, Jorge
    Soriano, Vincent
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (03) : 241 - 244